Aperio Group’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $1.37M | Buy |
6,218
+1,642
| +36% | +$361K | ﹤0.01% | 1424 |
|
|
2020
Q3 | $760K | Buy |
4,576
+2,543
| +125% | +$422K | ﹤0.01% | 1585 |
|
|
2020
Q2 | $232K | Buy |
+2,033
| New | +$232K | ﹤0.01% | 2133 |
|
|
2020
Q1 | – | Sell |
-1,679
| Closed | -$216K | – | 2413 |
|
|
2019
Q4 | $216K | Buy |
+1,679
| New | +$216K | ﹤0.01% | 2179 |
|
|
2019
Q3 | – | Sell |
-490
| Closed | -$50K | – | 2842 |
|
|
2019
Q2 | $50K | Buy |
+490
| New | +$50K | ﹤0.01% | 2533 |
|